Assessment of symptomatic women for early diagnosis of ovarian cancer: results from the prospective DOvE pilot project.
about
The molecular fingerprint of high grade serous ovarian cancer reflects its fallopian tube originSociety of Gynecologic Oncology recommendations for the prevention of ovarian cancerThe ovary is an alternative site of origin for high-grade serous ovarian cancer in mice.Ultrasound Monitoring of Extant Adnexal Masses in the Era of Type 1 and Type 2 Ovarian Cancers: Lessons Learned From Ovarian Cancer Screening Trials.Analysis of serial ovarian volume measurements and incidence of ovarian cancer: implications for pathogenesis.Phage display screening identifies a novel peptide to suppress ovarian cancer cells in vitro and in vivo in mouse models.Effect of quercetin on the proliferation of the human ovarian cancer cell line SKOV-3 in vitro.Sprouty2 protein in prediction of post-treatment ascites in epithelial ovarian cancer treated with adjuvant carbotaxol chemotherapy.Methoxyphenyl chalcone sensitizes aggressive epithelial cancer to cisplatin through apoptosis induction and cancer stem cell eradication.Comparison of HE4, CA125, and Risk of Ovarian Malignancy Algorithm in the Prediction of Ovarian Cancer in Korean Women.Molecular Alterations of TP53 are a Defining Feature of Ovarian High-Grade Serous Carcinoma: A Rereview of Cases Lacking TP53 Mutations in The Cancer Genome Atlas Ovarian Study.Prophylactic salpingo-oophorectomy in BRCA1 mutation carriers and postoperative incidence of peritoneal and breast cancers.Time to diagnosis of Type I or II invasive epithelial ovarian cancers: a multicentre observational study using patient questionnaire and primary care records.Preventing ovarian cancer by salpingectomy.In vitro and in vivo correlates of physiological and neoplastic human Fallopian tube stem cells.Early detection of ovarian and fallopian tube cancer by examination of cytological samples from the endometrial cavity.Diagnostic potential of tumor DNA from ovarian cyst fluid.Experience of symptoms indicative of gynaecological cancers in UK women.Refining Ovarian Cancer Test accuracy Scores (ROCkeTS): protocol for a prospective longitudinal test accuracy study to validate new risk scores in women with symptoms of suspected ovarian cancer.Symptoms, CA125 and HE4 for the preoperative prediction of ovarian malignancy in Brazilian women with ovarian masses.Value of symptom-triggered diagnostic evaluation for ovarian cancer.Through the glass darkly: intraepithelial neoplasia, top-down differentiation, and the road to ovarian cancer.Role of Nerve Growth Factor (NGF) and miRNAs in Epithelial Ovarian Cancer.Diagnostic and referral intervals for Manitoba women with epithelial ovarian cancer - the Manitoba Ovarian Cancer Outcomes (MOCO) study group: a retrospective cross-sectional studyOvarian cancer: diagnostic, biological and prognostic aspects.Primary peritoneal clear cell carcinoma versus ovarian carcinoma versus malignant transformation of endometriosis: a vexing issue.Anticancer effect and mechanism of polymer micelle-encapsulated quercetin on ovarian cancer.Estimating the Prevalence of Ovarian Cancer Symptoms in Women Aged 50 Years or Older: Problems and PossibilitiesEpigenetic biomarkers in the diagnosis of ovarian cancer.Postmenopausal hormone therapy-also use of estradiol plus levonorgestrel-intrauterine system is associated with an increased risk of primary fallopian tube carcinoma.Cancer of the ovary, fallopian tube, and peritoneum.Screening for ovarian cancer: imaging challenges and opportunities for improvement.First International Consensus Report on Adnexal Masses: Management Recommendations.Cohort studies in the context of obstetric and gynecologic research: a methodologic overview.
P2860
Q27008375-4575EB21-4D26-4F47-A1DE-3A86D77E9205Q27009306-6EA0B78F-B2BE-4245-A53D-8F412AB0AD98Q33569721-82CC1820-5A9A-4D36-ADF0-1BBB0B57760DQ33850475-D9309782-8436-4625-975A-96D03D38EB52Q34209092-3564CB98-6127-4939-BE71-092D434625E0Q35837404-4795EF53-B24D-43D6-AE93-6EFEE3094F08Q35856641-AFB6D1BF-2C29-4A03-989A-8048D72298DDQ36057153-21F9ABC1-65AA-41B8-819B-3DF60DBEC176Q36361670-3C89F9AE-9058-4019-9205-AA1A609588D0Q36400522-E8E7D002-B500-4147-89DE-4D7E24CC011DQ36416465-E4715257-E003-4AB9-8045-E25BA569249AQ36634141-C113BC90-C181-4DB5-BF6A-867D7E10F5DCQ36866311-EB64D359-0EEE-4A58-8075-EFAB7C174D56Q36897728-C04C1EAA-6392-4D04-81B6-8A33448F2733Q36976183-10876DCC-14AE-4EF9-9D56-5FE8FD147779Q37081960-57AD4A05-798E-4063-844D-015EE1E15899Q37098838-4C8BBCA7-C5F7-4E58-957F-6D73F7F85D26Q37111189-ADA81C55-3EF2-4A73-8AA3-C6CD9F40F683Q37177372-41C66851-1682-42E4-B6E2-78C20835AC28Q37359954-3FE1E27A-6BD2-41FF-AC76-649DE5722408Q37524514-9E91A072-1CA1-4682-8E3F-E7B0912AA5C3Q37626525-710EFAEC-6D56-425F-9367-E79922360C87Q37729033-6E2AC857-3749-4F85-B0B6-359BF207A3ECQ37735899-DA2A902F-218A-4290-976B-0FEFF47C64CBQ38261795-11E5E53E-E226-4BF4-91A7-1D4879434B85Q38365195-04A145A1-E7F7-4C4F-8453-2892788FBED1Q39264067-D3C7C905-D43A-486E-AB26-71F14EADEA5FQ39294212-E65F36A1-D40F-4C5A-A806-337815B7AF5EQ39453522-2BB379D3-29C1-4A3D-B1AA-9C32270587E8Q41110434-98790550-9EDE-405D-82CE-7B0402A80E89Q41266914-BC7753BE-DC2F-4F3C-A084-31196F5629FAQ43557526-1A614112-FE24-4575-907C-35024BD77513Q47948339-3BC132A3-6156-4BF3-9938-02E6704DC324Q48197978-3AA0E96F-FB72-4221-8AB7-EA219B5E04A3
P2860
Assessment of symptomatic women for early diagnosis of ovarian cancer: results from the prospective DOvE pilot project.
description
2012 nî lūn-bûn
@nan
2012 թուականի Յունուարին հրատարակուած գիտական յօդուած
@hyw
2012 թվականի հունվարին հրատարակված գիտական հոդված
@hy
2012年の論文
@ja
2012年論文
@yue
2012年論文
@zh-hant
2012年論文
@zh-hk
2012年論文
@zh-mo
2012年論文
@zh-tw
2012年论文
@wuu
name
Assessment of symptomatic wome ...... rospective DOvE pilot project.
@ast
Assessment of symptomatic wome ...... rospective DOvE pilot project.
@en
type
label
Assessment of symptomatic wome ...... rospective DOvE pilot project.
@ast
Assessment of symptomatic wome ...... rospective DOvE pilot project.
@en
prefLabel
Assessment of symptomatic wome ...... rospective DOvE pilot project.
@ast
Assessment of symptomatic wome ...... rospective DOvE pilot project.
@en
P2093
P1433
P1476
Assessment of symptomatic wome ...... rospective DOvE pilot project.
@en
P2093
Agnihotram V Ramanakumar
Claudia Martins
DOvE Study Group
Giovanni Artho
Janet Takefman
John Sampalis
Louise Quintal
Lucy Gilbert
P304
P356
10.1016/S1470-2045(11)70333-3
P50
P577
2012-01-17T00:00:00Z